Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

Cited In for PubMed (Select 21492761)

1.

Heart failure: advanced development in genetics and epigenetics.

Yang J, Xu WW, Hu SJ.

Biomed Res Int. 2015;2015:352734. doi: 10.1155/2015/352734. Epub 2015 Apr 9. Review.

2.

A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia.

Liu GS, Morales A, Vafiadaki E, Lam CK, Cai WF, Haghighi K, Adly G, Hershberger RE, Kranias EG.

Cardiovasc Res. 2015 Jul 1;107(1):164-74. doi: 10.1093/cvr/cvv127. Epub 2015 Apr 7.

PMID:
25852082
3.

Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes.

Dell'Era P, Benzoni P, Crescini E, Valle M, Xia E, Consiglio A, Memo M.

World J Stem Cells. 2015 Mar 26;7(2):329-42. doi: 10.4252/wjsc.v7.i2.329. Review.

4.

Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy.

Gramlich M, Pane LS, Zhou Q, Chen Z, Murgia M, Schötterl S, Goedel A, Metzger K, Brade T, Parrotta E, Schaller M, Gerull B, Thierfelder L, Aartsma-Rus A, Labeit S, Atherton JJ, McGaughran J, Harvey RP, Sinnecker D, Mann M, Laugwitz KL, Gawaz MP, Moretti A.

EMBO Mol Med. 2015 Mar 9;7(5):562-76. doi: 10.15252/emmm.201505047.

5.

Exome sequencing establishes diagnosis of Alström syndrome in an infant presenting with non-syndromic dilated cardiomyopathy.

Long PA, Evans JM, Olson TM.

Am J Med Genet A. 2015 Apr;167A(4):886-90. doi: 10.1002/ajmg.a.36994. Epub 2015 Feb 23.

PMID:
25706677
6.

Familial dilated cardiomyopathy: Current challenges and future directions.

Fatkin D.

Glob Cardiol Sci Pract. 2012 Aug 27;2012(1):8. doi: 10.5339/gcsp.2012.8. eCollection 2012. Review. No abstract available.

7.

Sudden cardiac death diagnosed with dilated cardiomyopathy in a Kuwaiti family: a case report.

Bulbanat B, Antony D, Behbehani K, Alsmadi O, Thomas D, Kamkar MM.

BMC Res Notes. 2014 Dec 16;7:914. doi: 10.1186/1756-0500-7-914.

8.

Importance of genetic evaluation and testing in pediatric cardiomyopathy.

Tariq M, Ware SM.

World J Cardiol. 2014 Nov 26;6(11):1156-65. doi: 10.4330/wjc.v6.i11.1156. Review.

9.

Cardiac troponin T (TNNT2) mutations in chinese dilated cardiomyopathy patients.

Li X, Luo R, Gu H, Deng Y, Xu X, Wu X, Hua W.

Biomed Res Int. 2014;2014:907360. doi: 10.1155/2014/907360. Epub 2014 Jul 7.

10.

The BAG3 gene variants in Polish patients with dilated cardiomyopathy: four novel mutations and a genotype-phenotype correlation.

Franaszczyk M, Bilinska ZT, Sobieszczańska-Małek M, Michalak E, Sleszycka J, Sioma A, Małek ŁA, Kaczmarska D, Walczak E, Włodarski P, Hutnik Ł, Milanowska B, Dzielinska Z, Religa G, Grzybowski J, Zieliński T, Ploski R.

J Transl Med. 2014 Jul 9;12:192. doi: 10.1186/1479-5876-12-192.

11.

Whole exome sequencing identifies a novel EMD mutation in a Chinese family with dilated cardiomyopathy.

Zhang M, Chen J, Si D, Zheng Y, Jiao H, Feng Z, Hu Z, Duan R.

BMC Med Genet. 2014 Jul 5;15:77. doi: 10.1186/1471-2350-15-77.

12.

Next-generation sequencing: from understanding biology to personalized medicine.

Frese KS, Katus HA, Meder B.

Biology (Basel). 2013 Mar 1;2(1):378-98. doi: 10.3390/biology2010378.

13.

RAF1 mutations in childhood-onset dilated cardiomyopathy.

Dhandapany PS, Razzaque MA, Muthusami U, Kunnoth S, Edwards JJ, Mulero-Navarro S, Riess I, Pardo S, Sheng J, Rani DS, Rani B, Govindaraj P, Flex E, Yokota T, Furutani M, Nishizawa T, Nakanishi T, Robbins J, Limongelli G, Hajjar RJ, Lebeche D, Bahl A, Khullar M, Rathinavel A, Sadler KC, Tartaglia M, Matsuoka R, Thangaraj K, Gelb BD.

Nat Genet. 2014 Jun;46(6):635-9. doi: 10.1038/ng.2963. Epub 2014 Apr 28.

14.

Biophysics, pathophysiology, and pharmacology of ion channel gating pores.

Moreau A, Gosselin-Badaroudine P, Chahine M.

Front Pharmacol. 2014 Apr 3;5:53. doi: 10.3389/fphar.2014.00053. eCollection 2014. Review.

15.

Genetics and heart failure: a concise guide for the clinician.

Skrzynia C, Berg JS, Willis MS, Jensen BC.

Curr Cardiol Rev. 2015;11(1):10-7. Review.

PMID:
24251456
16.

Genetics and epigenetics of arrhythmia and heart failure.

Duygu B, Poels EM, da Costa Martins PA.

Front Genet. 2013 Oct 30;4:219. doi: 10.3389/fgene.2013.00219. Review.

17.

Interpreting secondary cardiac disease variants in an exome cohort.

Ng D, Johnston JJ, Teer JK, Singh LN, Peller LC, Wynter JS, Lewis KL, Cooper DN, Stenson PD, Mullikin JC, Biesecker LG; NIH Intramural Sequencing Center (NISC) Comparative Sequencing Program.

Circ Cardiovasc Genet. 2013 Aug;6(4):337-46. doi: 10.1161/CIRCGENETICS.113.000039. Epub 2013 Jul 16.

18.

Short read (next-generation) sequencing: a tutorial with cardiomyopathy diagnostics as an exemplar.

Punetha J, Hoffman EP.

Circ Cardiovasc Genet. 2013 Aug;6(4):427-34. doi: 10.1161/CIRCGENETICS.113.000085. Epub 2013 Jul 14. No abstract available.

19.

Using genetic testing to guide therapeutic decisions in cardiomyopathy.

Lakdawala NK.

Curr Treat Options Cardiovasc Med. 2013 Aug;15(4):387-96. doi: 10.1007/s11936-013-0252-7.

20.

Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.

Valente AM, Lakdawala NK, Powell AJ, Evans SP, Cirino AL, Orav EJ, MacRae CA, Colan SD, Ho CY.

Circ Cardiovasc Genet. 2013 Jun;6(3):230-7. doi: 10.1161/CIRCGENETICS.113.000037. Epub 2013 May 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk